{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:08:21Z","timestamp":1791223701313,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T00:00:00Z","timestamp":1406678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1038\/ejhg.2014.145","type":"journal-article","created":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T06:20:22Z","timestamp":1406701222000},"page":"596-601","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":118,"title":["Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?"],"prefix":"10.1038","volume":"23","author":[{"given":"Eric","family":"Pasmant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Parfait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armelle","family":"Luscan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Goussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Briand-Suleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Laurendeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Fouveaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrystel","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelore","family":"Montadert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Wolkenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Vidaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Vidaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,30]]},"reference":[{"key":"BFejhg2014145_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1749-6632.1986.tb48061.x","volume":"486","author":"JC Carey","year":"1986","unstructured":"Carey JC, Baty BJ, Johnson JP, Morrison T, Skolnick M, Kivlin J : The genetic aspects of neurofibromatosis. Ann NY Acad Sci 1986; 486: 45\u201356.","journal-title":"Ann NY Acad Sci"},{"key":"BFejhg2014145_CR2","doi-asserted-by":"crossref","unstructured":"National Institutes of Health Consensus Development Conference Statement. Neurofibromatosis. Arch Neurol Chicago 1988; 45: 575\u2013578.","DOI":"10.1001\/archneur.1988.00520290115023"},{"key":"BFejhg2014145_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1212\/01.wnl.0000168830.79997.13","volume":"65","author":"T Tucker","year":"2005","unstructured":"Tucker T, Wolkenstein P, Revuz J, Zeller J, Friedman JM : Association between benign and malignant peripheral nerve sheath tumors in NF1. Neurology 2005; 65: 205\u2013211.","journal-title":"Neurology"},{"key":"BFejhg2014145_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/BF00208923","volume":"84","author":"M Clementi","year":"1990","unstructured":"Clementi M, Barbujani G, Turolla L, Tenconi R : Neurofibromatosis-1: a maximum likelihood estimation of mutation rate. Hum Genet 1990; 84: 116\u2013118.","journal-title":"Hum Genet"},{"key":"BFejhg2014145_CR5","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1086\/302809","volume":"66","author":"R Fahsold","year":"2000","unstructured":"Fahsold R, Hoffmeyer S, Mischung C et al: Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet 2000; 66: 790\u2013818.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2014145_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","volume":"15","author":"L Messiaen","year":"2000","unstructured":"Messiaen L, Callens T, Mortier G et al: Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 2000; 15: 541\u2013555.","journal-title":"Hum Mutat"},{"key":"BFejhg2014145_CR7","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1136\/jmg.40.6.e82","volume":"40","author":"E Ars","year":"2003","unstructured":"Ars E, Kruyer H, Morell M et al: Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients. J Med Genet 2003; 40: e82.","journal-title":"J Med Genet"},{"key":"BFejhg2014145_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/gcc.20289","volume":"45","author":"K Wimmer","year":"2006","unstructured":"Wimmer K, Yao S, Claes K et al: Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1100 unselected NF1 patients. Genes Chromosomes Cancer 2006; 45: 265\u2013276.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFejhg2014145_CR9","doi-asserted-by":"publisher","first-page":"E173","DOI":"10.1002\/humu.20826","volume":"29","author":"E Pros","year":"2008","unstructured":"Pros E, G\u00f3mez C, Mart\u00edn T, F\u00e1bregas P, Serra E, L\u00e1zaro C : Nature and mRNA effect of 282 different NF1 point mutations: focus on splicing alterations. Hum Mutat 2008; 29: E173\u2013E193.","journal-title":"Hum Mutat"},{"key":"BFejhg2014145_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jmoldx.2010.09.002","volume":"13","author":"MC Valero","year":"2011","unstructured":"Valero MC, Mart\u00edn Y, Hern\u00e1ndez-Imaz E et al: A highly sensitive genetic protocol to detect NF1 mutations. J Mol Diagn 2011; 13: 113\u2013122.","journal-title":"J Mol Diagn"},{"key":"BFejhg2014145_CR11","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/humu.22392","volume":"34","author":"A Sabbagh","year":"2013","unstructured":"Sabbagh A, Pasmant E, Imbard A et al: NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience. Hum Mutat 2013; 34: 1510\u20131518.","journal-title":"Hum Mutat"},{"key":"BFejhg2014145_CR12","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/jmg.2009.075937","volume":"47","author":"VF Mautner","year":"2010","unstructured":"Mautner VF, Kluwe L, Friedrich RE et al: Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4\u2009Mb type-1 NF1 deletions. J Med Genet 2010; 47: 623\u2013630.","journal-title":"J Med Genet"},{"key":"BFejhg2014145_CR13","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1086\/374821","volume":"72","author":"T De Raedt","year":"2003","unstructured":"De Raedt T, Brems H, Wolkenstein P et al: Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet 2003; 72: 1288\u20131292.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2014145_CR14","doi-asserted-by":"publisher","first-page":"E1506","DOI":"10.1002\/humu.21271","volume":"31","author":"E Pasmant","year":"2010","unstructured":"Pasmant E, Sabbagh A, Spurlock G et al: NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat 2010; 31: E1506\u2013E1518.","journal-title":"Hum Mutat"},{"key":"BFejhg2014145_CR15","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1136\/jmg.40.10.e109","volume":"40","author":"B Castle","year":"2003","unstructured":"Castle B, Baser ME, Huson SM, Cooper DN, Upadhyaya M : Evaluation of genotype-phenotype correlations in neurofibromatosis type 1. J Med Genet 2003; 40: e109.","journal-title":"J Med Genet"},{"key":"BFejhg2014145_CR16","first-page":"305","volume":"53","author":"DF Easton","year":"1993","unstructured":"Easton DF, Ponder MA, Huson SM, Ponder BA : An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet 1993; 53: 305\u2013313.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2014145_CR17","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/hmg\/ddp212","volume":"18","author":"A Sabbagh","year":"2009","unstructured":"Sabbagh A, Pasmant E, Laurendeau I et al: Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1. Hum Mol Genet 2009; 18: 2768\u20132778.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2014145_CR18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/jmedgenet-2012-100978","volume":"49","author":"E Pasmant","year":"2012","unstructured":"Pasmant E, Vidaud M, Vidaud D, Wolkenstein P : Neurofibromatosis type 1: from genotype to phenotype. J Med Genet 2012; 49: 483\u2013489.","journal-title":"J Med Genet"},{"key":"BFejhg2014145_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1086\/510781","volume":"80","author":"M Upadhyaya","year":"2007","unstructured":"Upadhyaya M, Huson SM, Davies M et al: An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970\u20132972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet 2007; 80: 140\u2013151.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2014145_CR20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S1470-2045(09)70033-6","volume":"10","author":"H Brems","year":"2009","unstructured":"Brems H, Beert E, de Ravel T, Legius E : Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol 2009; 10: 508\u2013515.","journal-title":"Lancet Oncol"},{"key":"BFejhg2014145_CR21","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/ng2113","volume":"39","author":"H Brems","year":"2007","unstructured":"Brems H, Chmara M, Sahbatou M et al: Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 2007; 39: 1120\u20131126.","journal-title":"Nat Genet"},{"key":"BFejhg2014145_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1136\/jmg.2008.065243","volume":"46","author":"E Pasmant","year":"2009","unstructured":"Pasmant E, Sabbagh A, Hanna N et al: SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. J Med Genet 2009; 46: 425\u2013430.","journal-title":"J Med Genet"},{"key":"BFejhg2014145_CR23","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/humu.22152","volume":"33","author":"H Brems","year":"2012","unstructured":"Brems H, Pasmant E, Van Minkelen R et al: Review and update of SPRED1 mutations causing Legius syndrome. Hum Mutat 2012; 33: 1538\u20131546.","journal-title":"Hum Mutat"},{"key":"BFejhg2014145_CR24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/humu.20246","volume":"26","author":"H Yu","year":"2005","unstructured":"Yu H, Zhao X, Su B et al: Expression of NF1 pseudogenes. Hum Mutat 2005; 26: 487\u2013488.","journal-title":"Hum Mutat"},{"key":"BFejhg2014145_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/jmg.2006.045906","volume":"44","author":"RE Ferner","year":"2007","unstructured":"Ferner RE, Huson SM, Thomas N et al: Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 2007; 44: 81\u201388.","journal-title":"J Med Genet"},{"key":"BFejhg2014145_CR26","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nbt.2198","volume":"30","author":"NJ Loman","year":"2012","unstructured":"Loman NJ, Misra RV, Dallman TJ et al: Performance comparison of benchtop high-throughput sequencing platforms. Nat Biotechnol 2012; 30: 434\u2013439.","journal-title":"Nat Biotechnol"},{"key":"BFejhg2014145_CR27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s12031-014-0286-7","volume":"53","author":"B Balla","year":"2014","unstructured":"Balla B, Arvai K, Horv\u00e1th P et al: Fast and robust next-generation sequencing technique using ion torrent personal genome machine for the screening of neurofibromatosis type 1 (NF1) gene. J Mol Neurosci 2014; 53: 204\u2013210.","journal-title":"J Mol Neurosci"},{"key":"BFejhg2014145_CR28","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/ejhg.2010.101","volume":"18","author":"CJ Mattocks","year":"2010","unstructured":"Mattocks CJ, Morris MA, Matthijs G et al: A standardized framework for the validation and verification of clinical molecular genetic tests. Eur J Hum Genet 2010; 18: 1276\u20131288.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg2014145_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrg3424","volume":"14","author":"LG Biesecker","year":"2013","unstructured":"Biesecker LG, Spinner NB : A genomic view of mosaicism and human disease. Nat Rev Genet 2013; 14: 307\u2013320.","journal-title":"Nat Rev Genet"},{"key":"BFejhg2014145_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1086\/519562","volume":"81","author":"O Maertens","year":"2007","unstructured":"Maertens O, De Schepper S, Vandesompele J et al: Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1. Am J Hum Genet 2007; 81: 243\u2013251.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2014145_CR31","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1212\/WNL.56.11.1433","volume":"56","author":"M Ruggieri","year":"2001","unstructured":"Ruggieri M, Huson SM : The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 2001; 56: 1433\u20131443.","journal-title":"Neurology"},{"key":"BFejhg2014145_CR32","first-page":"e25","volume":"42","author":"LM Messiaen","year":"2005","unstructured":"Messiaen LM, Wimmer K : Pitfalls of automated comparative sequence analysis as a single platform for routine clinical testing for NF1. J Med Genet 2005; 42: e25.","journal-title":"J Med Genet"},{"key":"BFejhg2014145_CR33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/jmg.2008.065474","volume":"46","author":"G Spurlock","year":"2009","unstructured":"Spurlock G, Bennett E, Chuzhanova N et al: SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype. J Med Genet 2009; 46: 431\u2013437.","journal-title":"J Med Genet"},{"key":"BFejhg2014145_CR34","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1001\/jama.2009.1663","volume":"302","author":"L Messiaen","year":"2009","unstructured":"Messiaen L, Yao S, Brems H et al: Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome. JAMA 2009; 302: 2111\u20132118.","journal-title":"JAMA"},{"key":"BFejhg2014145_CR35","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/ajmg.a.35718","volume":"161","author":"TM Muram","year":"2013","unstructured":"Muram TM, Stevenson DA, Watts-Justice S et al: A cost savings approach to SPRED1 mutational analysis in individuals at risk for neurofibromatosis type 1. Am J Med Genet A 2013; 161: 467\u2013472.","journal-title":"Am J Med Genet A"},{"key":"BFejhg2014145_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/humu.21418","volume":"32","author":"L Messiaen","year":"2011","unstructured":"Messiaen L, Vogt J, Bengesser K et al: Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1). Hum Mutat 2011; 32: 213\u2013219.","journal-title":"Hum Mutat"},{"key":"BFejhg2014145_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/humu.20601","volume":"29","author":"M Upadhyaya","year":"2008","unstructured":"Upadhyaya M, Kluwe L, Spurlock G et al: Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs). Hum Mutat 2008; 29: 74\u201382.","journal-title":"Hum Mutat"},{"key":"BFejhg2014145_CR38","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature12634","volume":"502","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, McLellan MD, Vandin F et al: Mutational landscape and significance across 12 major cancer types. Nature 2013; 502: 333\u2013339.","journal-title":"Nature"},{"key":"BFejhg2014145_CR39","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/ng.2762","volume":"45","author":"G Ciriello","year":"2013","unstructured":"Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C : Emerging landscape of oncogenic signatures across human cancers. Nat Genet 2013; 45: 1127\u20131133.","journal-title":"Nat Genet"},{"key":"BFejhg2014145_CR40","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1158\/2159-8290.CD-13-0017","volume":"3","author":"GT Gibney","year":"2013","unstructured":"Gibney GT, Smalley KS : An unholy alliance: cooperation between BRAF and NF1 in melanoma development and BRAF inhibitor resistance. Cancer Discov 2013; 3: 260\u2013263.","journal-title":"Cancer Discov"},{"key":"BFejhg2014145_CR41","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1158\/2159-8290.CD-12-0470","volume":"3","author":"SR Whittaker","year":"2013","unstructured":"Whittaker SR, Theurillat JP, Van Allen E et al: A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition. Cancer Discov 2013; 3: 350\u2013362.","journal-title":"Cancer Discov"},{"key":"BFejhg2014145_CR42","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1158\/2159-8290.CD-12-0313","volume":"3","author":"O Maertens","year":"2013","unstructured":"Maertens O, Johnson B, Hollstein P et al: Elucidating distinct roles for NF1 in melanomagenesis. Cancer Discov 2013; 3: 338\u2013349.","journal-title":"Cancer Discov"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg2014145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2014145","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2014145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:11:33Z","timestamp":1684415493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2014145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,30]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["BFejhg2014145"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2014.145","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,30]]},"assertion":[{"value":"21 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}